Wird geladen...
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...
Gespeichert in:
| Veröffentlicht in: | Drugs R D |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/ https://ncbi.nlm.nih.gov/pubmed/29546602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|